We observed markedly higher expression of TLR2, TLR3, TLR4, TLR7, TLR8, and TLR9 on CD4+, CD8+, and CD19+ lymphocytes in the endometriosis group, indicating their active participation in modulating immune responses in the disease setting. The gene discussed is CD19; the disease is endometriosis.